亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Safety and Effectiveness of Excimer Laser Ablation Combined With Drug-Coated Balloon for Atherosclerotic Obliterans in the Lower Extremity

医学 再狭窄 截肢 外科 闭塞性动脉硬化 严重肢体缺血 靶病变 临床终点 气球 动脉切除术 支架 烧蚀 病变 血管成形术 放射科 血管疾病 内科学 随机对照试验 动脉疾病 心肌梗塞 经皮冠状动脉介入治疗
作者
Xiaolang Jiang,Shuai Ju,Bin Chen,Junhao Jiang,Yun Shi,Tao Ma,Changpo Lin,Xin Xu,Weiguo Fu,Zhihui Dong
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:30 (5): 721-729 被引量:16
标识
DOI:10.1177/15266028221092979
摘要

PURPOSE: To evaluate the safety and effectiveness of excimer laser ablation (ELA) combined with drug-coated balloon (DCB) for atherosclerotic obliterans (ASO) of the lower extremities. MATERIALS AND METHODS: From June 2019 to December 2020, all eligible patients were enrolled. Demographics, characteristics of lesions, complications, and follow-up information were collected and analyzed. The primary endpoint was major amputation-free survival (MAFS). Secondary endpoints included technical success, primary patency, bailout stent, distal embolization, target lesion reintervention (TLR), and ulcer healing rate. Major amputation-free survival and primary patency were calculated by Kaplan-Meier analysis. RESULTS: A total of 71 patients were enrolled. Forty-eight (81.7%) patients presented critical limb ischemia (CLI) and 48.6% of them was calcification class 4 according to Peripheral Arterial Calcium Scoring System (PACSS). Chronic totally occluded (CTO) disease was the most common lesion in 66.0% of them and superficial femoral artery (SFA) was the most common segment in 59.6%. Technical success rate was 93.0%. One-year follow-up was finished in 25 (35.2%) patients. The primary patency and MAFS were 92.0%±27.6% and 96.0%±20.0% at 12 months, respectively. During the mean follow-up of 9.4±4.3 months, clinically-driven TLR occurred in 2 (2.8%) patients, and major and minor amputation occurred in 2 (2.8%) and 1 (1.4%) patient, respectively. CONCLUSION: The early results demonstrated that ELA was an effective treatment in de novo, in-stent restenosis (ISR) and CTO lesions. Meanwhile, ELA could prepare the lumen for the use of DCB and reduce the implantation of stents, especially in segments unsuitable for stenting. Mid-term and long-term results need to be awaited.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
6秒前
10秒前
www发布了新的文献求助10
10秒前
lucky完成签到 ,获得积分10
13秒前
Orange的应助被www采纳,获得10
23秒前
24秒前
29秒前
辛勤尔珍完成签到,获得积分10
37秒前
鲜艳的念寒完成签到,获得积分10
41秒前
小二郎的应助被科研通管家采纳,获得10
50秒前
风吹麦浪的应助被科研通管家采纳,获得20
50秒前
菌菌的应助被科研通管家采纳,获得10
50秒前
1分钟前
celinewu完成签到,获得积分10
1分钟前
事件的视界完成签到,获得积分10
1分钟前
面面面面包完成签到,获得积分10
1分钟前
迷人不可完成签到,获得积分10
1分钟前
空2完成签到 ,获得积分0
1分钟前
爱听歌未来完成签到,获得积分10
1分钟前
1分钟前
曾经凌萱发布了新的文献求助10
1分钟前
1分钟前
www发布了新的文献求助10
1分钟前
2分钟前
小蘑菇的应助被曾经凌萱采纳,获得10
2分钟前
2分钟前
炙热的香菱完成签到,获得积分10
2分钟前
忧虑的怀曼完成签到,获得积分10
2分钟前
复杂曼荷完成签到,获得积分10
2分钟前
2分钟前
小熊的桃子完成签到,获得积分10
2分钟前
科研通AI6.3的应助被www采纳,获得10
2分钟前
molihuakai的应助被面面面面包采纳,获得10
2分钟前
2分钟前
yeke完成签到,获得积分10
2分钟前
随机数学完成签到,获得积分10
2分钟前
2分钟前
完美世界的应助被科研通管家采纳,获得30
2分钟前
Maestro_S的应助被科研通管家采纳,获得10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179850
求助须知:如何正确求助?哪些是违规求助? 9570035
关于积分的说明 21808147
捐赠科研通 7775536
什么是DOI,文献DOI怎么找? 3433157
关于科研通互助平台的介绍 2557278
邀请新用户注册赠送积分活动 2478844